Ideas & Insights

Understanding the impact and the significance of the upcoming changes on Life Sciences companies and tax policies.

Companies abandoning plans for IPO or SPAC transactions should consider the deductibility of transaction costs and termination fees.

Issues to consider when incorporating a partnership to benefit from the qualified small business stock exclusion

Build your foundation of understanding about the complexities of VAT and GST and the impact they can have on U.S. multinational businesses.

Hear perspectives from RSM about transfer pricing trends and planning opportunities for the life sciences industry.

After 17 months of internal discussions, the German administration approved a draft bill to implement the EU Anti-Tax Avoidance Directives.

LB&I’s compliance campaign focuses on taxpayer reporting of purchase price allocations in taxable asset acquisitions.

UK government provides relief from DAC6, reducing the scope of reporting for UK intermediaries with cross-border transactions.

The IRS updated taxpayers on its operations status and recognized the delays in processing check payments due on July 15, 2020.

Applications to sell unused state net operating losses and state research and development credits available the week of May 1, 2020.

Here are some ways coronavirus could leave its mark on the global VAT, trade and tariff landscape for the life sciences industry.

Corporate taxpayers filing a consolidated return have an added layer of rules to navigate when carrying back a net operating loss.

The IRS provided long-awaited guidance for taxpayers anxious to take advantage of the NOL provisions in the CARES Act.

Recent guidance provides that certain deadlines, including the allowable time to invest in a QOF, are now extended because of COVID-19.

The IRS issued guidance extending the time for taxpayers to file certain Form 3115s and Form 1128s to July 15, 2020.

As businesses renegotiate debts in the aftermath of COVID-19, it is critical to understand whether the debt is considered publicly traded.

Accelerating worthless stock deductions on an insolvent subsidiary without disposing of the business to increase NOL carrybacks.

Delaware notices advise companies to either participate in the state’s unclaimed property VDA Program or be subject to an audit.

Department issued compliance alert explains the sales and use tax collection responsibilities for marketplace facilitators and sellers.

Three states have prescriptions for opioid taxes on manufacturers and distributors. Here’s what you need to know.